References
Barr Wh, Lin C-C, Radwanski E., Lim J., Symchowicz S. 1991. The Pharmacokinetics of Ceftibuten in Humans — Diagnostic Microbiology & Infectious Diseases 14:93–100.
Barry AL, Jones RN - 1990. The Collaborative Antimicrobial Susceptibility Testing Group-Interpretivecriteria & quality control limits for Ceftibuten disk susceptibility tests - J. Clinical Microbiology 28:605–607.
Bauemfeind A- 1991. Ceftibuten & Dactericidal kinetics. Comparative invitro activity againstenterobacteriaceae producing extended spectrum B-lactamases - Diagnostic Microbiology& Infections Dieseases 14:89–92.
Blummer JL, McLinn SE, DeAbate CA, Kafetzis DA, Perrotta RJ - 1993. Multinationalmulticenter controlled trial comparing Ceftibuten with Cefactor for the treatment of AcuteOtitis Media - Paediatric Infectious Disease Journal 12 (Suppl): S77-S83.
DeAbate CA, Prerrotta RJ, Dennington ML, Ziering RM - 1993. The efficacy & safety ofonce daily Ceftibuten compared with co-amoxiclav in the treatment of acute bacterialsinusitis - /. Chemotherapy 4:358–363.
Debbia EA, Pesce A, Chiesa M, Ricotta N. Schito GC - (1992.) Microbiological profile ofCeftibuten, a new oral cephalosporin - Drugs under Experimental & Clinical Research - 18:129–139.
Cooch WM. (1997.) Comparison of Cefixime and Amoxicillin / Clavulanic acid in AOM.P.I.D.J. 16(2)S21–24.
Fassbender M, Lode Schaberg T, Bomer K, Koeppe P - (1993.) Pharmacokinetics of neworal cephalosporins, including a new carbacephem - Clinical Infections Diseases 16: 646–653.
Jones RN, Barry AL. (1988). Antimicrobial activity, spectrum and recommendations for disk diffusion susceptibility testing of Ceftibuten. A new oral cephalosporin. Antimicrobial Agents and Chemotherapy 32: 1576–1582.
Lin C, Radwanski E, Lee L, Smith D, Symchowicz (1990.) Multiple dose pharmacokineticsof Ceftibuten (SCH 39270) in young adults & geriatric volunteers - 30th Interscience Conferenceon Antimicrobial Agents & Chemotherapy, Georgia - October 21-24. 1990. AbstractNo. 1172. P. 281.
McLinn SE, McCarthy JM, Perrotta R. Pichichero ME, Reidenberg BE-(1993.) Multicentercontrolled trial comparing Ceftibuten with Amox/Clav. in the empiric treatment of AcuteOtitis Media. Paed. Infectious Disease journal, 12:S70–76
Nakashima S, Nishimura K, Yoshimura K, Iwao N. Phase-(1988) clinical studies of 7432-S, a new oral cephalosporin: 1988 Safety and pharmacokinetics. Journal of Clinical Pharmacology 28: 246–252.
Neu HC Ceftibuten - (1993). Minimal inhibitory concentrations, post-antibiotic effect,Betalactarmase stability — a rationale for dosing programmes - Pediatric Infectious DiseaseJournal 12 (Suppl) S49-S54.
Pichichero ME, McLinn SE - (1993.) Ceftibuten vs phenoxymethylpenicillin in group Abetahemolytic streptococcal pharyngitis - Pediatric Infectious Disease Journal 12 (Suppl)S64-S70.
ShawarR, LaRocco M, Cleary TG- (1989.) Comparative invitro activity of Ceftibuten (Sch39720) against bacterial enteropathogens - Antimicrobial agents & Chemotterapy 33: 781–784.
Sterkers O - (1997). Efficacy & tolerability of Ceftibuten v/s Amoxycillin in treatment ofAcute Sinusitis - Chemotherapy 43(5) 352–7.
Verbist L, Jacobs J, Hens K - (1991.) Comparative antimicrobial activity of Ceftibutenagainst mutiply -resistant micro-organisms from Belgium - Diagnostic Microbiology &Infectious Diseases 14:53–61.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hathiram, B.T., Grewal, D.S., Tankwal, P. et al. Ceftibuten in ent infections. IJO & HNS 51, 104–107 (1999). https://doi.org/10.1007/BF02998005
Issue Date:
DOI: https://doi.org/10.1007/BF02998005